Paget's Disease of Bone

Ethel S. Siris, G. David Roodman

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Scopus citations

Abstract

This chapter discusses the etiology, pathology, clinical features, diagnosis, and treatment of Paget's disease. Although Paget's disease is the second most common bone disease after osteoporosis, the factors involved in its pathogenesis are just beginning to be clarified. Both genetic and environmental factors have been implicated in the pathophysiology of Paget's disease. The initiating lesion in Paget's disease is an increase in bone resorption due to an abnormality in the osteoclasts found at affected sites. Measurements of biochemical markers of bone turnover are useful clinically in the assessment of the extent and severity of disease in the untreated state and for monitoring the response to treatment. Specific antipagetic therapy consists of those agents capable of suppressing the activity of pagetic osteoclasts. Other symptomatic treatments for Paget's disease, including analgesics, anti-inflammatory drugs, use of orthotics or canes, and selected orthopedic and neurosurgical interventions, have important roles in management in many patients.

Original languageEnglish (US)
Title of host publicationPrimer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism: Eighth Edition
PublisherWiley Blackwell
Pages659-668
Number of pages10
ISBN (Electronic)9781118453926
ISBN (Print)9781118453889
DOIs
StatePublished - Jul 19 2013

Keywords

  • Antipagetic therapy
  • Bone remodeling
  • Osteoporosis
  • Paget's disease

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Paget's Disease of Bone'. Together they form a unique fingerprint.

Cite this